ICD-11 code 1F28.5 refers to disseminated dermatophytosis, a fungal infection of the skin. Dermatophytosis is a common skin condition caused by various types of fungi such as ringworm. Disseminated dermatophytosis means that the infection has spread extensively throughout the body.
This condition can manifest as red, scaly patches on the skin, along with itching and irritation. In severe cases, disseminated dermatophytosis can lead to widespread skin involvement and systemic symptoms. Treatment typically involves antifungal medications, both topical and oral, to eradicate the infection.
Table of Contents:
- #️⃣ Coding Considerations
- 🔎 Symptoms
- 🩺 Diagnosis
- 💊 Treatment & Recovery
- 🌎 Prevalence & Risk
- 😷 Prevention
- 🦠 Similar Diseases
#️⃣ Coding Considerations
The equivalent SNOMED CT code for the ICD-11 code 1F28.5, which represents disseminated dermatophytosis, is 238656003. SNOMED CT is a standardized medical terminology that helps healthcare professionals accurately document and exchange clinical information. The code 238656003 specifically denotes the presence of widespread dermatophytosis, a fungal skin infection that has spread beyond its initial site. By using SNOMED CT codes like 238656003, healthcare providers can easily communicate and share information about patient diagnoses, treatments, and outcomes. This standardized coding system improves the accuracy of medical records, enhances patient care coordination, and facilitates research and public health surveillance efforts related to dermatophytosis and other health conditions.
In the United States, ICD-11 is not yet in use. The U.S. is currently using ICD-10-CM (Clinical Modification), which has been adapted from the WHO’s ICD-10 to better suit the American healthcare system’s requirements for billing and clinical purposes. The Centers for Medicare and Medicaid Services (CMS) have not yet set a specific date for the transition to ICD-11.
The situation in Europe varies by country. Some European nations are considering the adoption of ICD-11 or are in various stages of planning and pilot studies. However, as with the U.S., full implementation may take several years due to similar requirements for system updates and training.
🔎 Symptoms
Symptoms of 1F28.5, also known as disseminated dermatophytosis, typically present as multiple circular or oval-shaped red, scaly patches on the skin. These patches may be itchy, and can sometimes form a ring-shaped pattern with raised edges. In some cases, the patches may be slightly raised, with a central clearing that gives them a distinctive appearance.
Patients with disseminated dermatophytosis may also experience hair loss in the affected areas, as the fungal infection can invade the hair follicles and cause hair breakage. Additionally, the skin lesions may be accompanied by inflammation, leading to redness, swelling, and tenderness at the site of infection. In severe cases, the infection can spread to other areas of the body, resulting in widespread skin involvement.
In some instances, disseminated dermatophytosis can lead to complications such as secondary bacterial infections, especially if the affected areas are scratched or irritated. These infections can manifest as pustules, crusting, or oozing sores on the skin. Patients with weakened immune systems or underlying medical conditions may be at a higher risk for developing disseminated dermatophytosis and experiencing more severe symptoms. Early detection and prompt treatment are essential to prevent the spread of the infection and minimize the risk of complications.
🩺 Diagnosis
Diagnosis of 1F28.5, disseminated dermatophytosis, involves a combination of physical examination, medical history review, and laboratory tests. Physicians begin by inspecting the affected areas of the skin for characteristic symptoms such as red, scaly patches or ring-shaped rashes. This visual inspection helps in identifying potential fungal infections.
In addition to the physical examination, doctors typically inquire about the patient’s recent activities, such as travel to regions with high fungal prevalence or close contact with infected individuals. This medical history review provides valuable information that can aid in establishing a diagnosis of disseminated dermatophytosis. Patients may be asked about any ongoing medications or treatments that could weaken their immune system and predispose them to fungal infections.
Laboratory tests are crucial for confirming the presence of dermatophyte fungi in the affected skin areas. Skin scrapings or samples may be collected and examined under a microscope to detect fungal elements. Additionally, cultures can be performed to isolate and identify the specific type of dermatophyte causing the infection. These diagnostic tests help in differentiating disseminated dermatophytosis from other skin conditions that share similar symptoms.
💊 Treatment & Recovery
Treatment options for 1F28.5, also known as disseminated dermatophytosis, typically involve the use of antifungal medications. Oral antifungal agents such as itraconazole or terbinafine are commonly prescribed to combat the spread of the infection throughout the body. Topical antifungal creams may also be recommended for localized areas of infection on the skin.
In some cases, more severe or widespread infections may require intravenous antifungal therapy to effectively treat the condition. These medications are administered directly into the bloodstream and can be more potent in targeting the fungal infection. It is important for individuals with disseminated dermatophytosis to follow the prescribed treatment regimen carefully and complete the full course of medication as directed by their healthcare provider.
Recovery from disseminated dermatophytosis can vary depending on the severity of the infection and the individual’s overall health. In most cases, with proper treatment and adherence to medication, patients can expect to see improvement in their symptoms within a few weeks. However, it is important to continue monitoring the skin for any signs of recurrence or development of new lesions even after the infection has cleared to prevent future outbreaks. Long-term follow-up care may be recommended to ensure the infection does not return.
🌎 Prevalence & Risk
In the United States, 1F28.5 (Disseminated dermatophytosis) is a relatively rare condition. It is estimated that only a small percentage of individuals are diagnosed with this disorder each year. However, the true prevalence may be higher due to underdiagnosis or misdiagnosis.
In Europe, the prevalence of 1F28.5 is also relatively low compared to other skin conditions. Cases of disseminated dermatophytosis are sporadically reported in various European countries, but they are not considered a major public health concern. The lack of extensive data on this condition makes it difficult to determine the exact prevalence in Europe.
In Asia, the prevalence of 1F28.5 is slightly higher than in the United States and Europe. Dermatophytosis, including the disseminated form, is more common in certain regions of Asia due to factors such as climate, hygiene practices, and population density. However, the exact prevalence of disseminated dermatophytosis in Asia is not well-documented and may vary among different countries.
In Africa, the prevalence of 1F28.5 is not well-studied, but cases of disseminated dermatophytosis have been reported in various regions of the continent. Factors such as poor sanitation, limited access to medical care, and cultural practices may contribute to the prevalence of this condition in certain African countries. More research is needed to accurately determine the prevalence of 1F28.5 in Africa.
😷 Prevention
Preventing disseminated dermatophytosis, also known as 1F28.5, involves several key strategies. One of the most important steps is maintaining good personal hygiene. This includes regular bathing, changing and washing clothes, and ensuring that living spaces are kept clean and free of moisture. By keeping the skin clean and dry, the risk of developing a dermatophyte infection is greatly reduced.
Another important aspect of prevention is avoiding contact with infected individuals or contaminated objects. Dermatophytes can easily spread through shared personal items such as towels, combs, and clothing. It is crucial to avoid sharing these items with others and to disinfect them regularly to prevent the transmission of the fungus.
In addition to personal hygiene practices, individuals can also reduce their risk of disseminated dermatophytosis by wearing appropriate footwear in public places such as locker rooms, swimming pools, and communal showers. These environments are often damp and warm, providing the perfect breeding ground for dermatophytes. Wearing protective footwear can help prevent direct contact with the fungus and reduce the risk of infection. By following these preventative measures, individuals can greatly reduce their risk of developing disseminated dermatophytosis.
🦠 Similar Diseases
One similar disease to 1F28.5, disseminated dermatophytosis, is tinea capitis. This fungal infection affects the scalp and hair follicles, leading to symptoms such as hair loss, scaling, and crusting. Tinea capitis is commonly seen in children, but can also affect adults.
Another disease closely related to disseminated dermatophytosis is tinea corporis. Also known as ringworm, tinea corporis is a superficial fungal infection of the skin that causes red, scaly patches or rings to appear. This condition is highly contagious and can be transmitted through direct contact with an infected person or contaminated objects.
A third disease comparable to 1F28.5 is tinea pedis, or athlete’s foot. This common fungal infection affects the feet, particularly between the toes, causing itching, redness, and peeling of the skin. Tinea pedis thrives in warm, moist environments such as locker rooms and swimming pools, making it a frequent occurrence among athletes and individuals who wear tight-fitting shoes.